Emerging evidence suggests that liquid–liquid phase separation (LLPS) represents a vital and ubiquitous phenomenon underlying the formation of membraneless organelles in eukaryotic cells (also known as biomolecular condensates or droplets). Recent studies have revealed evidences that indicate that LLPS plays a vital role in human health and diseases. In this review, we describe our current understanding of LLPS and summarize its physiological functions. We further describe the role of LLPS in the development of human diseases. Additionally, we review the recently developed methods for studying LLPS. Although LLPS research is in its infancy—but is fast-growing—it is clear that LLPS plays an essential role in the development of pathophysiological conditions. This highlights the need for an overview of the recent advances in the field to translate our current knowledge regarding LLPS into therapeutic discoveries.

Stretchable electronic materials have drawn strong interest due to their important applications in areas such as bioelectronics, wearable devices, and soft robotics. The stretchable electrode is an integral unit of stretchable systems. Intrinsically c o n d u c t i v e p o l y m e r s s u c h a s p o l y ( 3 , 4ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) can have high mechanical flexibility and good biocompatibility. However, their electrical conductivity and mechanical stretchability should be greatly improved for its applications as the stretchable electrode. Here, we report highly conductive and highly stretchable PEDOT:PSS by incorporating biocompatible D-sorbitol. D-Sorbitol can serve as both the secondary dopant and plasticizer for PEDOT:PSS. It can not only significantly improve the conductivity but also the stretchability. D-Sorbitol-PEDOT:PSS (s-PEDOT:PSS) can have a conductivity of >1000 S/cm, and the conductivity could be maintained at a strain up to 60%. The resistance of s-PEDOT:PSS remains almost constant during repeated stretching−releasing cycles. The mechanism for the stretchability improvement by D-sorbitol is ascribed to the softening of PSSH chains. D-Sorbitol can position among the PSSH chains and thus destructs the hydrogen bonds among the PSSH chains. This makes the conformational change of the PSSH chains under stress become easy and thus increases the mechanical flexibility of PEDOT:PSS. This conductivity is the highest for biocompatible intrinsically conductive polymers with high stretchability.

Edge computing provides a promising paradigm to support the implementation of industrial Internet of Things (IIoT) by offloading computational-intensive tasks from resourcelimited machine-type devices (MTDs) to powerful edge servers. However, the performance gain of edge computing may be severely compromised due to limited spectrum resources, capacity-constrained batteries, and context unawareness. In this paper, we consider the optimization of channel selection which is critical for efficient and reliable task delivery. We aim at maximizing the long-term throughput subject to longterm constraints of energy budget and service reliability. We propose a learning-based channel selection framework with service reliability awareness, energy awareness, backlog awareness, and conflict awareness, by leveraging the combined power of machine learning, Lyapunov optimization, and matching theory. We provide rigorous theoretical analysis, and prove that the proposed framework can achieve guaranteed performance with a bounded deviation from the optimal performance with global state information (GSI) based on only local and causal information. Finally, simulations are conducted under both single-MTD and multi-MTD scenarios to verify the effectiveness and reliability of the proposed framework.

Host cell proteins (HCPs) are process-related impurities that may copurify with biopharmaceutical drug products. Within this class of impurities there are some that are more problematic. These problematic HCPs can be considered high-risk and can include those that are immunogenic, biologically active, or enzymatically active with the potential to degrade either product molecules or excipients used in formulation. Some have been shown to be difficult to remove by purification. Why should the biopharmaceutical industry worry about these high-risk HCPs? What approach could be taken to understand the origin of its copurification and address these *Marisa Jones and Nisha Palackal should be considered joint first authors About Biophorum Development Group (BPDG): Since its inception in 2004, BioPhorum has become a trusted environment in which senior leaders of the biopharmaceutical industry come together to share and discuss openly the emerging trends and challenges facing their industry.BioPhorum currently comprises more than 3800 active participants in seven "phorums" covering cell and gene therapy, drug substance, development, fill-finish, a technology roadmap, information technology, and supply partners. The Host Cell Protein (HCP) Workstream is part of the Development Group (BPDG). This article is a composite view of opinions shared by the whole of the BPDG-HCP Workstream and should not be attributed to the individual positions of the participating companies.

No abstract